S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS

Detalles Bibliográficos
Autores principales: Demaria, Olivier, Habif, Guillaume, Le Floch, Francois, Muller, Marianna, Chiossone, Laura, Remark, Romain, Vetizou, Marie, Maurel, Nadia, Morel, Ariane, Gauthier, Laurent, Morel, Yannis, Paturel, Carine, Vivier, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428425/
http://dx.doi.org/10.1097/01.HS9.0000967944.12345.32

Ejemplares similares

Ejemplares similares